Anthony Petkidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthony Petkidis has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Urs F. Greber
Department of Molecular Life Sciences, University of Zurich
19 shared publications - Vardan Andriasyan
Department of Molecular Life Sciences, University of Zurich, Zurich, Switzerland
17 shared publications Luca Murer
Department of Molecular Life Sciences, University of Zürich, Winterthurerstrasse 190, Zürich, Switzerland
8 shared publicationsRomain Volle
University of Zürich
7 shared publications- Maarit Suomalainen
Department of Molecular Life Sciences, University of Zurich
4 shared publications - Abhyudai Singh
University of Delaware
3 shared publications
Latest Publications
- Open Access
- 29 October 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (10) , e0045424
Preexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
Viruses display large variability across all stages of their life cycle, including entry, gene expression, replication, assembly, and egress. We previously reported that the immediate early adenovirus (AdV) E1A transcripts accumulate in human lung epithelial A549 cancer cells with high variability, mostly independent of the number of incoming viral genomes, but somewhat correlated to the cell cycle state at the time of inoculation. Here, we leveraged the classical Luria–Delbrück fluctuation analysis to address whether infection variability primarily arises from the cell state or stochastic noise. The E1A expression was measured by the expression of green fluorescent protein (GFP) from the endogenous E1A promoter in AdV-C5_E1A-FS2A-GFP and found to be highly correlated with the viral plaque formation, indicating reliability of the reporter virus. As an ensemble, randomly picked clonal A549 cell isolates displayed significantly higher coefficients of variation in the E1A expression than technical noise, indicating a phenotypic variability larger than noise. The underlying cell state determining infection variability was maintained for at least 9 weeks of cell cultivation. Our results indicate that preexisting cell states tune adenovirus infection in favor of the cell or the virus. These findings have implications for antiviral strategies and gene therapy applications. IMPORTANCE: Viral infections are known for their variability. Underlying mechanisms are still incompletely understood but have been associated with particular cell states, for example, the eukaryotic cell division cycle in DNA virus infections. A cell state is the collective of biochemical, morphological, and contextual features owing to particular conditions or at random. It affects how intrinsic or extrinsic cues trigger a response, such as cell division or anti-viral state. Here, we provide evidence that cell states with a built-in memory confer high or low susceptibility of clonal human epithelial cells to adenovirus infection. Results are reminiscent of the Luria–Delbrück fluctuation test with bacteriophage infections back in 1943, which demonstrated that mutations, in the absence of selective pressure prior to infection, cause infection resistance rather than being a consequence of infection. Our findings of dynamic cell states conferring adenovirus infection susceptibility uncover new challenges for the prediction and treatment of viral infections.
- 29 October 2024
- Published by American Society for Microbiology in mSphere
- Vol. 9 (10) , e0045424
Open AccessPreexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
Viruses display large variability across all stages of their life cycle, including entry, gene expression, replication, assembly, and egress. We previously reported that the immediate early adenovirus (AdV) E1A transcripts accumulate in human lung epithelial A549 cancer cells with high variability, mostly independent of the number of incoming viral genomes, but somewhat correlated to the cell cycle state at the time of inoculation. Here, we leveraged the classical Luria–Delbrück fluctuation analysis to address whether infection variability primarily arises from the cell state or stochastic noise. The E1A expression was measured by the expression of green fluorescent protein (GFP) from the endogenous E1A promoter in AdV-C5_E1A-FS2A-GFP and found to be highly correlated with the viral plaque formation, indicating reliability of the reporter virus. As an ensemble, randomly picked clonal A549 cell isolates displayed significantly higher coefficients of variation in the E1A expression than technical noise, indicating a phenotypic variability larger than noise. The underlying cell state determining infection variability was maintained for at least 9 weeks of cell cultivation. Our results indicate that preexisting cell states tune adenovirus infection in favor of the cell or the virus. These findings have implications for antiviral strategies and gene therapy applications. IMPORTANCE: Viral infections are known for their variability. Underlying mechanisms are still incompletely understood but have been associated with particular cell states, for example, the eukaryotic cell division cycle in DNA virus infections. A cell state is the collective of biochemical, morphological, and contextual features owing to particular conditions or at random. It affects how intrinsic or extrinsic cues trigger a response, such as cell division or anti-viral state. Here, we provide evidence that cell states with a built-in memory confer high or low susceptibility of clonal human epithelial cells to adenovirus infection. Results are reminiscent of the Luria–Delbrück fluctuation test with bacteriophage infections back in 1943, which demonstrated that mutations, in the absence of selective pressure prior to infection, cause infection resistance rather than being a consequence of infection. Our findings of dynamic cell states conferring adenovirus infection susceptibility uncover new challenges for the prediction and treatment of viral infections.
- 16 August 2024
- Published by EMBL-EBI
Preexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
BioStudies – one package for all the data supporting a study
- 16 August 2024
- Published by EMBL-EBI
Preexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
BioStudies – one package for all the data supporting a study
- 15 August 2024
- Published by EMBL-EBI
Preexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
BioStudies – one package for all the data supporting a study
- 15 August 2024
- Published by EMBL-EBI
Preexisting cell state rather than stochastic noise confers high or low infection susceptibility of human lung epithelial cells to adenovirus
BioStudies – one package for all the data supporting a study
- Open Access
- 15 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
Virus infectivity is traditionally determined by endpoint titration in cell cultures, and requires complex processing steps and human annotation. Here we developed an artificial intelligence (AI)-powered automated framework for ready detection of virus-induced cytopathic effect (DVICE). DVICE uses the convolutional neural network EfficientNet-B0 and transmitted light microscopy images of infected cell cultures, including coronavirus, influenza virus, rhinovirus, herpes simplex virus, vaccinia virus, and adenovirus. DVICE robustly measures virus-induced cytopathic effects (CPE), as shown by class activation mapping. Leave-one-out cross-validation in different cell types demonstrates high accuracy for different viruses, including SARS-CoV-2 in human saliva. Strikingly, DVICE exhibits virus class specificity, as shown with adenovirus, herpesvirus, rhinovirus, vaccinia virus, and SARS-CoV-2. In sum, DVICE provides unbiased infectivity scores of infectious agents causing CPE, and can be adapted to laboratory diagnostics, drug screening, serum neutralization or clinical samples.
- 15 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-11
Open AccessA versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
Virus infectivity is traditionally determined by endpoint titration in cell cultures, and requires complex processing steps and human annotation. Here we developed an artificial intelligence (AI)-powered automated framework for ready detection of virus-induced cytopathic effect (DVICE). DVICE uses the convolutional neural network EfficientNet-B0 and transmitted light microscopy images of infected cell cultures, including coronavirus, influenza virus, rhinovirus, herpes simplex virus, vaccinia virus, and adenovirus. DVICE robustly measures virus-induced cytopathic effects (CPE), as shown by class activation mapping. Leave-one-out cross-validation in different cell types demonstrates high accuracy for different viruses, including SARS-CoV-2 in human saliva. Strikingly, DVICE exhibits virus class specificity, as shown with adenovirus, herpesvirus, rhinovirus, vaccinia virus, and SARS-CoV-2. In sum, DVICE provides unbiased infectivity scores of infectious agents causing CPE, and can be adapted to laboratory diagnostics, drug screening, serum neutralization or clinical samples.
- 26 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 26 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 26 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 26 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study
- 25 April 2024
- Published by EMBL-EBI
A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence
BioStudies – one package for all the data supporting a study